KLITH-250 Clarithromycin Tablets IP 250mg is a broad-spectrum macrolide antibiotic formulated to treat a wide range of bacterial infections. Each tablet contains 250 mg of clarithromycin as the active ingredient.
Key Features:
– Indication: KLITH-250 is primarily used to treat bacterial infections of the respiratory tract (such as bronchitis, pneumonia, sinusitis, and pharyngitis), as well as infections of the skin and soft tissues. It is also effective against certain ear, nose, and throat infections, and can be used in combination therapy for infections caused by Helicobacter pylori and for the prevention or treatment of Mycobacterium avium complex (MAC) in specific patient populations.
– Mechanism of Action: Clarithromycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and multiplication of susceptible bacteria.
– Dosage: The typical adult dosage is 250 mg every 12 hours for 7 to 14 days, depending on the severity and type of infection. Dosage may vary based on medical history and physician recommendations.
– Form: KLITH-250 is available as a film-coated tablet for oral administration. Tablets should be swallowed whole with water and can be taken with or without food.
– Quality Assurance: Manufactured by Aingo Pharma, KLITH-250 is produced under stringent GMP-certified practices, ensuring high quality and therapeutic effectiveness.
Precautions and Side Effects:
Common side effects may include stomach pain, diarrhea, nausea, and vomiting.
Serious side effects are rare but may include allergic reactions, severe diarrhea, or skin reactions.
Patients should complete the full prescribed course to ensure the infection is fully treated and to prevent antibiotic resistance.
Not suitable for viral infections such as the common cold or flu
